Read + Share
Li Y, Zhao B, Gao W, Wu Y, et al. Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits
bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway. Clin Exp Med 2026;26:62.
PMID: 41483418
|
 |
|
Li Y, Zhao B, Gao W, Wu Y, et al. Correction: LDB2 is a novel diagnostic and prognostic biomarker and inhibits
bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway. Clin Exp Med 2026;26:62.
PMID: 41483418
|
|
|
|